Involvement of G protein-coupled receptor kinase (GRK) 3 and GRK2 in down-regulation of the alpha2B-adrenoceptor

The Journal of Pharmacology and Experimental Therapeutics
Aarti N DesaiDouglas C Eikenburg

Abstract

Increasing the cellular levels of G protein-coupled receptor kinase (GRK) 2 or GRK3 renders the alpha2B-adrenoceptor (AR) more sensitive to agonist-induced down-regulation (J Pharmacol Exp Ther 312:767-773, 2005). However, an absolute requirement of GRK3 and GRK2 for alpha2B-AR down-regulation is controversial. In this study, using NG108 cells (endogenous alpha2B-AR), we provide strong evidence for a critical role of both GRK3 and GRK2 in down-regulation of the alpha2B-AR. Pretreatment of NG108 cells with 20 microM epinephrine (EPI) begins down-regulating the alpha2B-AR by 2 h. The translocation of GRK3 and GRK2 to the membrane peaks at 30 min, decreasing by 1 h. Although these results may implicate GRK3 and GRK2 in alpha2B-AR down-regulation, significant receptor down-regulation is not observed until 2 h, after GRK3 and GRK2 translocation has peaked and is declining. To more directly establish a role for GRK3 and GRK2 in alpha2B-AR down-regulation, NG108 cells were transfected to express GRK3ct, which binds to liberated Gbetagamma subunits, preventing GRK3 and GRK2 translocation to the membrane. Overexpression of GRK3ct prevented not only the translocation of GRK3 and GRK2 but also the down-regulation of the alpha2B-AR caused ...Continue Reading

References

May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J L BenovicR J Lefkowitz
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·M G EasonS B Liggett
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·J IngleseR J Lefkowitz
May 1, 1997·Molecular Pharmacology·D A DauntB K Kobilka
Apr 18, 1998·The Journal of Biological Chemistry·A W GagnonJ L Benovic
Mar 2, 1999·British Journal of Pharmacology·C CaylaH Paris
May 20, 2000·The Journal of Biological Chemistry·S HoffenbergB J Knoll
Jan 11, 2001·Trends in Cardiovascular Medicine·R B PennJ L Benovic
Dec 4, 2001·Brain Research. Molecular Brain Research·M ShapiraY Sarne
Jun 13, 2003·European Journal of Cell Biology·Tuire Olli-LähdesmäkiJaana Kallio
Jun 12, 2004·The Journal of Pharmacology and Experimental Therapeutics·Aarti N DesaiDouglas C Eikenburg
Oct 1, 2004·The Journal of Pharmacology and Experimental Therapeutics·Aarti N DesaiDouglas C Eikenburg

❮ Previous
Next ❯

Citations

Dec 4, 2014·Autonomic Neuroscience : Basic & Clinical·Fernando E SantiagoDaniel C Carrettiero
Apr 6, 2007·The European Journal of Neuroscience·Wendy KleibeukerAnnemieke Kavelaars
Jan 27, 2007·The Journal of Pharmacology and Experimental Therapeutics·Samina SalimDouglas C Eikenburg
Apr 16, 2008·European Journal of Pharmacology·Mariëlle C Hendriks-BalkAstrid E Alewijnse

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.